Concepedia

Rosemary M. Cesario

RM

9

Publications

1.6K

Citations

9

H-Index

1997

Active since

Affiliations

Ligand Pharmaceuticals (United States)(Current)

ViaCyte (United States)

Molecular Oncology (United States)

Rosemary M. Cesario is an author at Ligand Pharmaceuticals (United States) specializing in medicine, cell signaling, and pharmacology.

Top concepts

Publications per year

1997–2021

9

Publications

9

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

Ranjan Mukherjee, Peter J. Davies, Diane L. Crombie et al. · Nature · 1997 · 610 citations

, , +9

A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells

Thomas C. Schulz, Holly Young, Alan D. Agulnick et al. · PLoS ONE · 2012 · 429 citations · Full text

Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo

Alan D. Agulnick, Dana M. Ambruzs, Mark A. Moorman et al. · Stem Cells Translational Medicine · 2015 · 241 citations · Full text

Rosiglitazone Induction of Insig-1 in White Adipose Tissue Reveals a Novel Interplay of Peroxisome Proliferator-activated Receptor γ and Sterol Regulatory Element-binding Protein in the Regulation of Adipogenesis

Heidi R. Kast-Woelbern, Sharon Dana, Rosemary M. Cesario et al. · Journal of Biological Chemistry · 2004 · 106 citations · Full text

Differentiation and growth inhibition mediated via the RXR:PPARγ heterodimer in colon cancer

Rosemary M. Cesario, Jessica Stone, Wan-Ching Yen et al. · Cancer Letters · 2005 · 78 citations

, , +11

Rows per page

1–5 of 9